IMS Health to buy clinical trials enrollment software company DecisionView

IMS Health will buy DecisionView, a San Francisco software company focusing on clinical enrollment, the companies said Tuesday. Financial terms of the deal weren’t disclosed. DecisionView, which has about 40 employees, sells software to clinical trials organizations that help them plan, forecast and track patient enrollment. It has zeroed in on life science companies, which are charged on a per-trial basis for a web-based product, called StudyOptimizer.